Research

Chiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)-a potential mechanism for the anti-cancer effects of ibuprofen


Reference:

Woodman, T. J., Wood, P. J., Thompson, A. S., Hutchings, T. J., Steel, G. R., Jiao, P., Threadgill, M. D. and Lloyd, M. D., 2011. Chiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)-a potential mechanism for the anti-cancer effects of ibuprofen. Chemical Communications, 47 (26), pp. 7332-7334.

Related documents:

[img]
Preview
PDF (Ibuprofen AMACR) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (1277kB) | Preview

    Official URL:

    http://dx.doi.org/10.1039/c1cc10763a

    Abstract

    Metabolic chiral inversion of 2-arylpropanoic acids (2-APAs;double dagger 'profens'), such as ibuprofen, is important for pharmacological activity. Several 2-APA-CoA esters were good racemisation substrates for human AMACR 1A, suggesting a common chiral inversion pathway for all 2-APAs and an additional mechanism for their anti-cancer properties.

    Details

    Item Type Articles
    CreatorsWoodman, T. J., Wood, P. J., Thompson, A. S., Hutchings, T. J., Steel, G. R., Jiao, P., Threadgill, M. D. and Lloyd, M. D.
    DOI10.1039/c1cc10763a
    DepartmentsFaculty of Science > Pharmacy & Pharmacology
    RefereedYes
    StatusPublished
    ID Code24764

    Export

    Actions (login required)

    View Item

    Document Downloads

    More statistics for this item...